These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33814454)

  • 21. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Ruan L; Kang Z; Pei G; Le Y
    Curr Alzheimer Res; 2009 Dec; 6(6):531-40. PubMed ID: 19747158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous knockout of cytosolic phospholipase A
    Qu B; Gong Y; Gill JM; Kenney K; Diaz-Arrastia R
    Brain Res; 2017 Sep; 1670():248-252. PubMed ID: 28648388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.
    Andersen JV; Christensen SK; Aldana BI; Nissen JD; Tanila H; Waagepetersen HS
    Neurochem Res; 2017 Jun; 42(6):1589-1598. PubMed ID: 27686658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
    Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y
    Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
    Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
    Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-fat diet induced discrepant peripheral and central nervous systems insulin resistance in APPswe/PS1dE9 and wild-type C57BL/6J mice.
    Guo Y; Ma X; Li P; Dong S; Huang X; Ren X; Yuan L
    Aging (Albany NY); 2020 Dec; 13(1):1236-1250. PubMed ID: 33291072
    [No Abstract]   [Full Text] [Related]  

  • 31. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 34. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
    Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
    Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques.
    Sala Frigerio C; Wolfs L; Fattorelli N; Thrupp N; Voytyuk I; Schmidt I; Mancuso R; Chen WT; Woodbury ME; Srivastava G; Möller T; Hudry E; Das S; Saido T; Karran E; Hyman B; Perry VH; Fiers M; De Strooper B
    Cell Rep; 2019 Apr; 27(4):1293-1306.e6. PubMed ID: 31018141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.
    Liu YL; Chen WT; Lin YY; Lu PH; Hsieh SL; Cheng IH
    Mol Neurodegener; 2017 Apr; 12(1):30. PubMed ID: 28438208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglia in Alzheimer's Disease.
    Süß P; Schlachetzki JCM
    Curr Alzheimer Res; 2020; 17(1):29-43. PubMed ID: 32048973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
    Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
    Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.